Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections

Journal of the American Board of Family Medicine

Volumn 22, Issue 6, 2009, Pages 647-654

  Crawford, Susan E ^a   David, Michael Z ^a   Glikman, Daniel ^a,b   King, Kimberly J ^a   Boyle Vavra, Susan ^a   Daum, Robert S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; HUMAN; MAJOR CLINICAL STUDY; MEC GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PREDICTION; PVL GENE; SKIN INFECTION; SOFT TISSUE INFECTION; SUPPURATION;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL SKIN INFECTIONS; SUPPURATION;

EID: 70849112656     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2009.06.090025     Document Type: Article

References (37)

1. Barber M. Methicillin-resistant staphylococci. J Clin Pathol 1961;14:385-393
2. Barrett FF, McGehee RF, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. N Eng J Med 1968;279:441-448
3. Doebbeling BN. The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection. J Chemother 1995;7(Suppl 3):99-103.
4. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598
5. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin- resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999;48:707-710
6. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984
7. Ito T, Katayama Y, Asada K, et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001;45:1323-1336 (Pubitemid 32374098)
8. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin- resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148:249-257
9. Han LL, McDougal LK, Gorwitz RJ, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol 2007; 45:1350-1352
10. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002;46:1147-1152
11. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin- resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002;186:1344-1347
12. Vandenesch F, Naimi T, Enright MC, et al. Community- acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: world-wide emergence. Emerg Infect Dis 2003;9:978-984
13. Fridkin SK, Hageman JC, Morrison M, et al. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-1444
14. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse- Friderichsen syndrome in children. N Engl J Med 2005;353:1245-1251
15. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100-107
16. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-1453
17. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001;32(Suppl):S114-32.
18. Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39:47-54.
19. Klevens RM, Morrison MA, Nadle J, et al. Active Bacterial Core Surveillance MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-1771
20. David MZ, Glikman D, Crawford SE, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008;197:1235-1243
21. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare- associated infections. Emerg Infect Dis 2007; 13:236-242
22. Gonzalez BE, Rueda AM, Shelburne SA 3rd, Musher DM, Hamill RJ, Hulten KG. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006;27:1051-1056
23. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004;39:1460-1466
24. Saiman L, O'Keefe M, Graham PL 3rd, et al. Hospital transmission of community-acquired methicillin- resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003;37:1313-1319
25. Klevens RM, Morrison MA, Fridkin SK, et al. Community- associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006;12:1991-1993
26. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing. 14th Informational Supplement. Villanova, PA: National Committee for Clinical Laboratory Standards; 2004.
27. David MZ, Crawford SE, Boyle-Vavra S, Hostetler MA, Kim DC, Daum RS. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerg Infect Dis 2006;12:631-637
28. Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant community-associated methicillin- resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylcoccal chromosome cassette (SCCmec) type VT or SCCmec type IV. J Clin Micro 2005;43:4719-4730
29. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005;40:1785-1791
30. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin- resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-674
31. Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007;357:380-390
32. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002;21:530-534
33. Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillin- resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007;51:423-428
34. Voyich JM, Otto M, Mathema B, et al. Is Panton- Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006;194: 1761-1770
35. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007;23:1130-1133
36. Ward PD, Turner WH. Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect Immun 1980;28:393-397
37. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin- susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007;44:471-482